Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LEGEND BIOTECH CORPORATION

(LEGN)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 02-12-2022
50.92 USD   +2.31%
22/11Genscript Biotech Unit krijgt goedkeuring van de Amerikaanse FDA voor de klinische ontwikkeling van een therapie tegen kleincellige longkanker.
MT
21/11Legend Biotech Corporation kondigt FDA goedkeuring aan van IND aanvraag voor LB2102 in uitgebreid stadium van kleincellige longkanker
CI
03/11Legend Biotech Corporation deelt bijgewerkte gegevens van uitgebreid klinisch ontwikkelingsprogramma Cilta-Cel op ASH 2022
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
ETF's gepositioneerd op LEGEND BIOTECH CORPORATIONETF's en trackers met Trackinsight
ETF gewichtVariatie 5 dagenRatingGeografie
Loncar Cancer Immunotherapy ETF - USD2.86%1.71%-Wereld
Global X MSCI China Health Care ETF - USD1.94%4.62%China
Loncar China BioPharma ETF - Distributing - USD1.63%11.01%China
Virtus LifeSci Biotech Products ETF - USD1.38%4.06%VS
First Trust US Equity Opportunities - USD1.08%-0.50%VS
First Trust US Equity Opportunities ETF - USD1.06%0.51%VS
KraneShares MSCI All China Health Care Inde...0.95%4.54%China
KraneShares Emerging Market Healthcare Inde...0.74%3.06%NC
Renaissance IPO ETF - USD0.52%4.75%-VS
IShares Biotechnology ETF - USD0.51%3.44%-NC
IShares Nasdaq US Biotechnology (D) - USD0.22%2.61%VS
IShares Nasdaq US Biotechnology - USD0.22%2.66%VS
Invesco Nasdaq Biotechnology ETF - USD0.21%2.68%-VS
UBS ETF - MSCI China ESG Universal Low Carb...0.15%8.42%-NC
Invesco MSCI Emerging Markets ESG Climate P...0.13%4.75%-NC
HSBC MSCI CHINA - USD0.11%11.78%China
IShares MSCI China ETF - USD0.11%7.52%-China
IShares MSCI China - Accumulating - USD0.11%12.02%China
IShares MSCI China - Dist - USD0.11%9.11%-China
Xtrackers MSCI China 1C - USD0.11%11.99%China
Xtrackers MSCI China 1D - USD0.11%11.17%-China
Lyxor MSCI Disruptive Technology ESG Filter...0.1%1.48%-Wereld
Deka MSCI China ex A Shares - HKD0.09%13.59%China
IShares MSCI BRIC ETF - USD0.09%6.07%Wereld
Invesco MSCI China All Shares Stock Connect - USD0.06%9.85%-NC
IShares MSCI AC Far East ex-Japan Acc - USD0.05%5.75%-Azië
IShares MSCI AC Far East ex-Japan - USD0.05%6.49%Azië
IShares MSCI EM Asia - USD0.04%5.95%Azië
IShares MSCI All Country Asia ex Japan ETF - USD0.04%0.00%Azië
Amundi Index MSCI Emerging Markets DR - USD0.04%4.36%-NC
Nomura NEXT FUNDS Emerging Market Equity MS...0.03%0.22%-NC
AMUNDI INDEX MSCI EMERGING MARKETS DR (D) - EUR0.03%3.50%-NC
AMUNDI INDEX MSCI EMERGING MARKETS DR (C) - EUR0.03%2.23%-NC
Xtrackers MSCI Emerging Markets Hedged Equi...0.03%3.45%NC
IShares MSCI Emerging Markets ETF - USD0.03%4.14%NC
SPDR MSCI Emerging Markets StrategicFactors...0.03%3.54%Wereld
V-Shares US Leadership Diversity ETF - USD0.02%1.49%-NC
Fidelity NASDAQ Composite Index ETF - USD0.02%2.06%-VS
IShares MSCI ACWI ex U.S. ETF - USD0.01%2.58%Wereld
IShares Core MSCI All Country World ex Cana...0%2.23%Wereld
IShares Core MSCI All Country World ex Cana...0%3.38%-Wereld



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ďInformationĒ) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Grafiek LEGEND BIOTECH CORPORATION
Duur : Periode :
Legend Biotech Corporation : Grafische technische analyse Legend Biotech Corporation | MarketScreener
Grafiek op volledig scherm
Evolutie van de resultatenrekening
Consensus
Verkoop
Koop
Gemiddeld advies Kopen
Aantal analisten 11
Laatste slotkoers 50,92 $
Gemiddelde koersdoel 68,00 $
Spread / Gemiddelde doel 33,5%
Grafiek LEGEND BIOTECH CORPORATION
Duur : Periode :
Legend Biotech Corporation : Grafische technische analyse Legend Biotech Corporation | MarketScreener
Grafiek op volledig scherm
Sector en concurrentie
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
LEGEND BIOTECH CORPORATION9.25%8 524
VERTEX PHARMACEUTICALS46.34%82 493
REGENERON PHARMACEUTICALS, INC.20.54%81 852
BIONTECH SE-34.16%41 250
WUXI APPTEC CO., LTD.-34.47%32 173
GENMAB A/S24.60%30 178